Study Stopped
Specialised equipment required withdrawn from market
Safety Study of Keyhole Gallbladder Surgery With Removal of Gallbladder Via the Stomach Rather Than Through the Skin
Safety and Feasibility Trial of Laparoscopic Small Port Cholecystectomy With Transgastric Gallbladder Recovery
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The benefits of laparoscopic ("minimally invasive" or "keyhole") surgery for gallbladder removal (cholecystectomy) over open surgical procedures in terms of significant reductions in pain, scarring and recovery time are well accepted. In a conventional laparoscopic cholecystectomy however, the excised gallbladder still has to be extracted through the abdominal wall skin via a laparoscopic port site using an incision of 10mm or greater. Despite being much smaller than that required for open surgery, this incision is painful, leaves a scar and can result in a port site hernia to follow requiring further surgery to repair it. Recent attempts to further reduce the invasiveness of the surgical procedure have suggested performing the operation via an endoscope passed through the mouth and through an incision in the stomach wall - so called Natural Orifice Translumenal Endoscopic Surgery (NOTES). Unlike a skin incision, an incision in the wall of the stomach (gastrotomy) should give no pain, visible scar or herniation risk yet still allow access to the peritoneal cavity for surgical procedures such as cholecystectomy. Against this, it has the potential risks of contamination and leakage of gastric contents into the peritoneal cavity. Whilst the limitations of present technology make it very difficult to perform an entire cholecystectomy through the stomach wall in patients, endoscopic methods for closing a gastrotomy are available that are approved for use in patients (CE marked) and it is hypothesised that removing the excised gallbladder through the stomach in this way would avoid the problems of extracting it through the abdominal wall described above. Data are required to determine whether the extraction of the gallbladder via a gastrotomy rather than through the skin is safe, producing smaller scars and a better cosmetic result. A secondary endpoint would be to assess possible reductions in pain and recovery from this less invasive approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 7, 2009
CompletedFirst Posted
Study publicly available on registry
November 10, 2009
CompletedStudy Start
First participant enrolled
December 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedFebruary 5, 2014
February 1, 2014
4.2 years
November 7, 2009
February 4, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
This is a pilot study aimed at examining the outcomes of gallbladder recovery through a gastrotomy, concentrating on safety. The main outcome is presence of surgical complications.
6 months
Secondary Outcomes (1)
Secondary outcomes include pain levels and cosmetic satisfaction
6 months
Interventions
The gallbladder is dissected as for a standard laparoscopic cholecystectomy but is then recovered via a hole in the stomach created and closed endoscopically rather than through the skin as in the standard fashion
Eligibility Criteria
You may qualify if:
- Fit patients, avoiding extremes of age, with uncomplicated gallstone disease requiring elective laparoscopic cholecystectomy.
You may not qualify if:
- Direct healthcare team deny permission to approach patient for trial.
- Patient request / preference.
- Age (\< 21 or \> 65 yrs old).
- Co-morbidity (ASA level 3 or above).
- BMI \> 32.
- Complicated gallstone disease (eg bile duct stones/ERCP/pancreatitis).
- Gallstones ≥ 18 mm size (too large to recover via oesophagus).
- Pregnancy.
- Previous gastric or upper abdominal surgery (alterations in gastric anatomy or adhesions preventing safe gastrotomy).
- Emergency procedure.
- Planned other operation during cholecystectomy.
- Inability to consent or psychiatric or addiction problems relevant to surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Colchester Hospital University NHS Foundation Trustlead
- Ethicon, Inc.collaborator
Study Sites (1)
Colchester General Hospital
Colchester, Essex, CO4 5JL, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ralph Austin, MS, FRCS
Colchester General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant laparoscopic surgeon
Study Record Dates
First Submitted
November 7, 2009
First Posted
November 10, 2009
Study Start
December 1, 2009
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
February 5, 2014
Record last verified: 2014-02